Paper40468448
Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer.
Yan F and 5 others. Cell Commun Signal, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer. Papers, record 40468448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40468448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| I-kappa B Kinase | Major topic |
| Extracellular Matrix | Major topic |
| Carcinoma, Intraductal, Noninfiltrating | Major topic |
| Signal Transduction | Major topic |
| Humans | |
| Female | |
| Phenotype | |
| Cell Line, Tumor | |
| Neoplasm Invasiveness | |
| Cell Proliferation |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29134745 | Mechanosignalling in tumour progression. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/29134745 | PubMed |
| 2 | 30279728 | Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling. | Theranostics | 2018 | https://conductscience.org/library/papers/30279728 | PubMed |
| 3 | 28754442 | Mechanotransduction at the cell-matrix interface. | Semin Cell Dev Biol | 2017 | https://conductscience.org/library/papers/28754442 | PubMed |
| 4 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 5 | 17613324 | Demystifying the effects of a three-dimensional microenvironment in tissue morphogenesis. | Methods Cell Biol | 2007 | https://conductscience.org/library/papers/17613324 | PubMed |
| 6 | 29048430 | Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/29048430 | PubMed |
| 7 | 16169468 | Tensional homeostasis and the malignant phenotype. | Cancer Cell | 2005 | https://conductscience.org/library/papers/16169468 | PubMed |
| 8 | 32472133 | Dynamic extracellular matrix stiffening induces a phenotypic transformation and a migratory shift in epithelial cells. | Integr Biol (Camb) | 2020 | https://conductscience.org/library/papers/32472133 | PubMed |
| 9 | 29510460 | The extracellular matrix as a key regulator of intracellular signalling networks. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/29510460 | PubMed |
| 10 | 19931152 | Matrix crosslinking forces tumor progression by enhancing integrin signaling. | Cell | 2009 | https://conductscience.org/library/papers/19931152 | PubMed |
| 11 | 27396337 | Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer. | Cell Rep | 2016 | https://conductscience.org/library/papers/27396337 | PubMed |
| 12 | 39744441 | TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/39744441 | PubMed |
| 13 | 19567681 | Kinome profiling in pediatric brain tumors as a new approach for target discovery. | Cancer Res | 2009 | https://conductscience.org/library/papers/19567681 | PubMed |
| 14 | 25959051 | Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. | Integr Biol (Camb) | 2015 | https://conductscience.org/library/papers/25959051 | PubMed |
| 15 | 32832636 | Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer. | Sci Adv | 2020 | https://conductscience.org/library/papers/32832636 | PubMed |
| 16 | 34063627 | JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34063627 | PubMed |
| 17 | 16632515 | Adjusting batch effects in microarray expression data using empirical Bayes methods. | Biostatistics | 2007 | https://conductscience.org/library/papers/16632515 | PubMed |
| 18 | 21547576 | Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. | Cell Oncol (Dordr) | 2011 | https://conductscience.org/library/papers/21547576 | PubMed |
| 19 | 24978026 | Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. | PLoS One | 2014 | https://conductscience.org/library/papers/24978026 | PubMed |
| 20 | 32147542 | Fibrosis and cancer: A strained relationship. | Biochim Biophys Acta Rev Cancer | 2020 | https://conductscience.org/library/papers/32147542 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797373 | Marbofloxacin Suppresses Breast Cancer Growth Through Oxidative Stress and Metabolic Reprogramming with Predicted HSP90AA1-EGFR Network Modulation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797373 | PubMed |
| 41226237 | c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth. | Molecules | 2025 | https://conductscience.org/library/papers/41226237 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IKBKE | 9641 | PubTator's text mining | https://conductscience.org/library/genes/9641 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40468448
GET https://conductscience.org/api/papers/v1/40468448/references?page=2